NexImmune, Inc. (NASDAQ:NEXI – Get Free Report)’s share price shot up 2,169,900% during mid-day trading on Tuesday . The stock traded as high as $2.17 and last traded at $2.17. 12,837 shares changed hands during trading, an increase of 176% from the average session volume of 4,645 shares. The stock had previously closed at $0.0001.
NexImmune Stock Up 2,169,900.0%
The company has a fifty day simple moving average of $0.05. The company has a market capitalization of $3.03 million, a P/E ratio of -0.12 and a beta of 1.98.
About NexImmune
NexImmune, Inc is a clinical‐stage biotechnology company focused on developing novel T‐cell immunotherapies to treat cancer, autoimmune disease and persistent viral infections. The company’s core innovation is its proprietary artificial thymic organoid (ATO) platform, which generates naïve T cells capable of recognizing specific antigens. By guiding T‐cell development in vitro, NexImmune aims to create targeted, high‐potency therapeutic candidates that leverage the body’s natural immune response.
The company’s pipeline includes multiple product candidates at various stages of development.
Further Reading
- Five stocks we like better than NexImmune
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
